Amgen (AMGN)

240.50 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (1/29/20 *Est.)

Latest Headlines

Qiagen (QGEN) Builds on Global Collaboration With Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer January 13, 2020 4:21 PM - StreetInsider Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer January 13, 2020 4:20 PM - PR NewsWire Guardant Health (GH) Announces Collaboration With Amgen (AMGN) to Develop a Global Liquid Biopsy Companion Diagnostic for AMG 510 KRAS G12C Inhibitor January 13, 2020 8:41 AM - StreetInsider Amgen To Present At The 38th Annual J.P. Morgan Healthcare Conference January 9, 2020 4:00 PM - PR NewsWire Amgen (AMGN) PT Raised to $275 at BMO Capital January 9, 2020 6:56 AM - StreetInsider Amgen (AMGN) IV flat into JPMorgan 38th Annual Healthcare Conference January 13-16 January 8, 2020 10:19 AM - StreetInsider Form 3 AMGEN INC For: Jan 01 Filed by: Griffith Peter H. January 7, 2020 6:37 PM - SEC Filing Amgen To Present At The Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference January 7, 2020 4:00 PM - PR NewsWire Amgen (AMGN) Case Against Amneal Sent Back to Trial Court - Bloomberg January 7, 2020 9:55 AM - StreetInsider Form 8-K AMGEN INC For: Jan 02 January 2, 2020 8:36 AM - SEC Filing Amgen (AMGN) Commences Strategic Collaboration With BeiGene (BGNE) to Expand Oncology Presence in China January 2, 2020 8:17 AM - StreetInsider Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China January 2, 2020 8:15 AM - PR NewsWire BeiGene Announces Closing of Amgen Global Strategic Oncology Collaboration and Equity Investment January 2, 2020 8:15 AM - Globe NewsWire Amgen (AMGN) call put ratio 4.1 calls to 1 put with focus on June 240 and 260 calls December 30, 2019 2:18 PM - StreetInsider UPDATE: Raymond James Starts Amgen (AMGN) at Market Perform December 23, 2019 5:42 PM - StreetInsider Amgen (AMGN) option implied volatility at low end of range December 20, 2019 10:33 AM - StreetInsider Amgen (AMGN) option implied volatility at low end of range December 20, 2019 10:27 AM - StreetInsider Amgen (AMGN) PT Raised to $277 at Cowen December 20, 2019 7:43 AM - StreetInsider Amgen (AMGN), Allergan (AGN) Submit BLA For ABP 798, Biosimilar Candidate To Rituxan, to FDA December 19, 2019 4:45 PM - StreetInsider Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan® (rituximab), To U.S. Food And Drug Administration December 19, 2019 4:44 PM - PR NewsWire Morgan Stanley Resumes Amgen (AMGN) at Overweight December 17, 2019 8:39 AM - StreetInsider Wall Street sets records anew on trade deal boost December 16, 2019 8:13 AM - StreetInsider Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy December 16, 2019 5:05 AM - StreetInsider Form 4 AMGEN INC For: Dec 13 Filed by: Piacquad David December 13, 2019 8:32 PM - SEC Filing Amgen (AMGN) PT Raised to $250 at Credit Suisse December 13, 2019 7:39 AM - StreetInsider Form 8-K AMGEN INC For: Dec 12 December 12, 2019 8:40 AM - SEC Filing Amgen (AMGN), UCB Announce EC Approves EVENITY for Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture December 12, 2019 6:20 AM - StreetInsider European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture December 12, 2019 1:00 AM - PR NewsWire Amgen (AMGN) Raises Quarterly Dividend 10.3% to $1.60; 2.7% Yield December 11, 2019 4:00 PM - StreetInsider Amgen Announces 10% Increase In 2020 First Quarter Dividend December 11, 2019 4:00 PM - PR NewsWire Amgen (AMGN) Reports Data from Phase 3 CANDOR Study Combining KYPROLIS (carfilzomib) And DARZALEX December 10, 2019 7:33 AM - StreetInsider Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) To Be Presented During Late-Breaking Session At American Society Of Hematology Annual Meeting December 10, 2019 7:30 AM - PR NewsWire Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease December 9, 2019 4:00 PM - PR NewsWire Amgen Selects Location For R&D Facility In The South San Francisco Biotechnology Hub December 9, 2019 9:00 AM - PR NewsWire Amgen (AMGN) PT Raised to $265 at Argus December 9, 2019 8:10 AM - StreetInsider Amgen (AMGN) Confirms FDA Approved its AVSOLA For Same Indications as Remicade December 6, 2019 2:34 PM - StreetInsider FDA Approves Amgen's AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab) December 6, 2019 2:32 PM - PR NewsWire Amgen (AMGN) gains FDA approval of biosimilar Avsola December 6, 2019 10:59 AM - StreetInsider Abarca, Amgen Enter Outcome-Based Agreement For Enbrel December 3, 2019 9:10 AM - PR NewsWire Amgen Announces Data Being Presented At ASH 2019 December 2, 2019 4:00 PM - PR NewsWire Amgen (AMGN) PT Raised to $250 at Oppenheimer December 2, 2019 7:46 AM - StreetInsider Form 4 AMGEN INC For: Nov 25 Filed by: Meline David W November 25, 2019 6:27 PM - SEC Filing Form 4 AMGEN INC For: Nov 22 Filed by: Graham Jonathan P November 25, 2019 6:25 PM - SEC Filing Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker November 24, 2019 4:00 PM - StreetInsider Amgen (AMGN) PT Raised to $230 at BofA/Merrill Lynch November 22, 2019 8:34 AM - StreetInsider Amgen (AMGN) PT Raised to $265 at SunTrust November 22, 2019 6:52 AM - StreetInsider Form 8-K AMGEN INC For: Nov 21 November 21, 2019 6:57 AM - SEC Filing Amgen (AMGN) Completes Acquisition Of Otezla, Updates Guidance November 21, 2019 6:26 AM - StreetInsider Amgen Completes Acquisition Of Otezla® (apremilast) November 21, 2019 6:21 AM - PR NewsWire Form 4 AMGEN INC For: Nov 20 Filed by: Piacquad David November 20, 2019 8:10 PM - SEC Filing Bristol-Myers Squibb (BMY) Completes Acquisition of Celgene (CELG) November 20, 2019 4:16 PM - StreetInsider Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company November 20, 2019 4:16 PM - BizWire Amgen (AMGN), Cytokinetics (CYTK) Announces New Results From COSMIC-HF Presented at AHA November 18, 2019 9:06 AM - StreetInsider New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function November 18, 2019 9:00 AM - Globe NewsWire New Results From COSMIC-HF Presented At AHA 2019 Show Treatment Of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral Or Improved Measures Of Diastolic Function November 18, 2019 9:00 AM - PR NewsWire Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha® (evolocumab) In High-Risk Patients Who Have Experienced A Recent Heart Attack November 16, 2019 9:00 AM - PR NewsWire Bristol-Myers (BMY) Receives FTC Clearance for Celgene (CELG) Acquisition, Deal Expected to Close Next Week November 15, 2019 5:57 PM - StreetInsider Bristol-Myers Squibb Receives Clearance from U.S. Federal Trade Commission for Celgene Acquisition November 15, 2019 4:55 PM - BizWire Amgen And The Duke Clinical Research Institute Announce Initiation Of First Large-Scale Registry To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors November 15, 2019 9:00 AM - PR NewsWire UPDATE: SunTrust Starts Amgen (AMGN) at Buy November 12, 2019 4:31 AM - StreetInsider Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio November 11, 2019 9:00 AM - PR NewsWire Form 4 AMGEN INC For: Nov 06 Filed by: Williams R Sanders November 7, 2019 6:22 PM - SEC Filing Form 4 AMGEN INC For: Nov 06 Filed by: SUGAR RONALD D November 7, 2019 6:21 PM - SEC Filing Amgen To Present At The 28th Annual Credit Suisse Healthcare Conference November 7, 2019 5:01 PM - PR NewsWire Form 4 AMGEN INC For: Nov 01 Filed by: Johnston Lori A November 5, 2019 6:56 PM - SEC Filing Form 4 AMGEN INC For: Nov 01 Filed by: Graham Jonathan P November 5, 2019 6:54 PM - SEC Filing Form 4 AMGEN INC For: Nov 02 Filed by: Gordon Murdo November 5, 2019 6:50 PM - SEC Filing Form 4 AMGEN INC For: Nov 01 Filed by: Kullman Ellen Jamison November 5, 2019 6:44 PM - SEC Filing Form 4 AMGEN INC For: Nov 01 Filed by: HOLLEY CHARLES M November 5, 2019 6:42 PM - SEC Filing UPDATE: Cantor Fitzgerald Upgrades Amgen (AMGN) to Overweight November 5, 2019 6:03 AM - StreetInsider BeiGene, Ltd. (BGNE) PT Raised to $210 at Maxim Group November 4, 2019 7:53 AM - StreetInsider Pre-Open Movers 11/01: (BGNE) (CRC) (LOCO) Higher; (ANET) (CASA) (PINS) Lower (more...) November 1, 2019 9:28 AM - StreetInsider After-Hours Movers 10/31: (BGNE) (LOCO) (QRVO) Higher; (ANET) (CASA) (PINS) Lower (more...) October 31, 2019 5:25 PM - StreetInsider Form 8-K AMGEN INC For: Oct 31 October 31, 2019 5:06 PM - SEC Filing Amgen (AMGN) will acquire 20.5% stake in BeiGene (BGNE) for approximately $2.7 billion in cash October 31, 2019 4:01 PM - StreetInsider BeiGene Announces Global Strategic Oncology Collaboration with Amgen October 31, 2019 4:00 PM - Globe NewsWire Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China October 31, 2019 4:00 PM - PR NewsWire The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature October 30, 2019 6:00 PM - PR NewsWire Amgen (AMGN) PT Raised to $205 at SVB Leerink October 30, 2019 9:33 AM - StreetInsider Amgen (AMGN) PT Raised to $253 at Cowen October 30, 2019 7:45 AM - StreetInsider Amgen (AMGN) PT Raised to $225 at Credit Suisse October 30, 2019 7:14 AM - StreetInsider Amgen (AMGN) PT Raised to $245 at Citi October 30, 2019 6:14 AM - StreetInsider Form 10-Q AMGEN INC For: Sep 30 October 30, 2019 6:09 AM - SEC Filing Form 8-K AMGEN INC For: Oct 29 October 29, 2019 5:09 PM - SEC Filing Amgen (AMGN) Tops Q3 EPS by 13c, Revenues Beat; Raises FY19 EPS/Revenue Guidance October 29, 2019 4:03 PM - StreetInsider Amgen Reports Third Quarter 2019 Financial Results October 29, 2019 4:01 PM - PR NewsWire Amgen (AMGN) Pushes to Session Highs October 29, 2019 1:10 PM - StreetInsider Mizuho Securities Reiterates Neutral Rating on Amgen (AMGN) October 29, 2019 7:23 AM - StreetInsider Amgen Announces Webcast of 2019 Third Quarter Financial Results October 24, 2019 4:00 PM - PR NewsWire Form CT ORDER AMGEN INC October 24, 2019 9:06 AM - SEC Filing Amgen (AMGN) to Make Repatha Available Exclusively at Lower List Price Option October 24, 2019 9:01 AM - StreetInsider Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020 October 24, 2019 9:00 AM - PR NewsWire Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corporation October 23, 2019 4:00 PM - PR NewsWire Amgen (AMGN) CFO David Meline to Retire October 23, 2019 6:19 AM - StreetInsider Form 8-K AMGEN INC For: Oct 22 October 23, 2019 6:07 AM - SEC Filing David Meline, Amgen's Chief Financial Officer, To Retire October 22, 2019 7:22 PM - PR NewsWire U.S. charges six investment bankers over insider trading scheme October 22, 2019 5:54 PM - StreetInsider Amgen (AMGN) Declares $1.45 Quarterly Dividend; 2.8% Yield October 22, 2019 4:00 PM - StreetInsider Amgen Announces 2019 Fourth Quarter Dividend October 22, 2019 4:00 PM - PR NewsWire Full Article List